Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Practical guidelines on the use of insulin lispro in elderly diabetic patients.

Benbarka MM, Prescott PT, Aoki TT.

Drugs Aging. 1998 Feb;12(2):103-13. Review.

PMID:
9509289
2.
3.

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Giugliano D, Ceriello A, Razzoli E, Esposito K.

Clin Drug Investig. 2008;28(4):199-210. Review.

PMID:
18345710
4.

Insulin lispro: a review of its use in the management of diabetes mellitus.

Simpson D, McCormack PL, Keating GM, Lyseng-Williamson KA.

Drugs. 2007;67(3):407-34. Review.

PMID:
17335298
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group..

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
7.

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.

Reynolds NA, Wagstaff AJ.

Drugs. 2004;64(17):1957-74. Review.

PMID:
15329046
8.

Premixed insulin analogues for the treatment of diabetes mellitus.

Garber AJ.

Drugs. 2006;66(1):31-49. Review.

PMID:
16398567
9.

[Short-acting insulin analogs].

Wolffenbuttel BH, Heine RJ.

Ned Tijdschr Geneeskd. 1998 Feb 21;142(8):397-400. Dutch.

PMID:
9562773
10.

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.

PMID:
10743981
11.

Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.

Skrha J, Smahelová A, Andĕl M, Vrtovec M, Subić J, Kreze A, Vozar J, Korecová M, de Verga V, Wyatt J, Metcalfe S, Ristić S.

Sb Lek. 2002;103(1):15-21.

PMID:
12448933
12.

[An update on multiple insulin injection therapy in type 1 and 2 diabetes].

Varanauskiene E, Varanauskaite I, Ceponis J.

Medicina (Kaunas). 2006;42(9):770-9. Review. Lithuanian.

14.

Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.

García L, Lamas C, Tuset MJ, Alonso M, Barrio R.

Diabetes Nutr Metab. 2002 Feb;15(1):7-13.

PMID:
11942742
15.

Clinical strategies for controlling peaks and valleys: type 1 diabetes.

Bolli GB.

Int J Clin Pract Suppl. 2002 Jul;(129):65-74. Review.

PMID:
12166610
16.

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

Diabetes Care. 1998 Oct;21(10):1627-31.

PMID:
9773721
17.

Insulin lispro: new preparation. Faster acting.

[No authors listed]

Prescrire Int. 1998 Jun;7(35):67-8.

PMID:
10342918
18.

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S.

Diabetes. 1999 Jan;48(1):99-105.

PMID:
9892228
19.

Insulin glulisine.

Robinson DM, Wellington K.

Drugs. 2006;66(6):861-9.

PMID:
16706558

Supplemental Content

Support Center